As of May 04
| +0.15 / +1.11%|
The 6 analysts offering 12-month price forecasts for Cardiovascular Systems Inc have a median target of 16.00, with a high estimate of 17.50 and a low estimate of 12.00. The median estimate represents a +17.04% increase from the last price of 13.67.
The current consensus among 7 polled investment analysts is to Buy stock in Cardiovascular Systems Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.